Citadel Advisors’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Citadel Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-114,209	Closed	-$8.58K	–	16232
2022 Q4	$8.58K	Buy	+114,209	New	+$52.4K	﹤0.01%	13742
2022 Q3	–	Sell	-1,896,856	Closed	-$4.04M	–	14088
2022 Q2	$2.83M	Buy	+1,896,856	New	+$8.72M	﹤0.01%	4866

Other funds holding CORZ

SFS

Sowell Financial Services North Little Rock, Arkansas $2.7B AUM 22.62% 1-Year Est. Return

CWC

Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return

BWP

BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Citadel Advisors's CORZ Position: Q1 2023 in Review

Citadel Advisors sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 114,209 shares — an estimated $8.58K sold.

Citadel Advisors first reported a position in CORZ in Q2 2022 and held it in 2 quarters. The position peaked at $2.83M in Q2 2022. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

Citadel Advisors reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Citadel Advisors sold 114,209 Core Scientific, Inc. Common Stock shares in Q1 2023, an estimated $8.58K.
Citadel Advisors first reported a position in Core Scientific, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Citadel Advisors's Core Scientific, Inc. Common Stock position peaked at $2.83M in Q2 2022.
10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.